Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

ALLIANCE: Sikkerhet og effektivitet av SAPIEN X4 Transcatheter Heart Valve

22. september 2026 oppdatert av: Edwards Lifesciences

Sikkerhet og effektivitet av ballongutvidbar bioprotese SAPIEN X4 transkateterhjerteklaff

The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects with symptomatic, severe, calcific aortic stenosis (AS).

Studieoversikt

Status

Rekruttering

Detaljert beskrivelse

This is a prospective, single arm, multicenter study. Subjects with bicuspid aortic valve morphology will be enrolled in a separate registry.

Studietype

Intervensjonell

Registrering (Antatt)

1234

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • Parkville, Australia, 3050
        • Aktiv, ikke rekrutterende
        • The Royal Melbourne Hospital
    • Queensland
      • Spring Hill, Queensland, Australia, 4000
        • Aktiv, ikke rekrutterende
        • St. Andrews War Memorial Hospital
    • South Australia
      • Adelaide, South Australia, Australia, 5000
        • Aktiv, ikke rekrutterende
        • Royal Adelaide Hospital
    • British Columbia
      • Vancouver, British Columbia, Canada, V6E 1M7
        • Aktiv, ikke rekrutterende
        • St. Paul's Hospital System
    • Ontario
      • Hamilton, Ontario, Canada, L8L 2X2
        • Aktiv, ikke rekrutterende
        • Hamilton Health Services
    • Quebec
      • Québec, Quebec, Canada, G1V 4G5
        • Aktiv, ikke rekrutterende
        • Institut Universitaire de Cardiologie et de Pneumologie de Quebec- Universite Laval
    • California
      • La Jolla, California, Forente stater, 92037
        • Aktiv, ikke rekrutterende
        • Scripps Memorial Hospital La Jolla
      • Los Angeles, California, Forente stater, 90048
        • Rekruttering
        • Cedars-Sinai Medical Center
      • Los Angeles, California, Forente stater, 90027
        • Aktiv, ikke rekrutterende
        • Kaiser Los Angeles
      • Newport Beach, California, Forente stater, 92663
        • Aktiv, ikke rekrutterende
        • Hoag Memorial Hospital Presbyterian
      • Sacramento, California, Forente stater, 95817
        • Rekruttering
        • UC Davis Medical Center Sacramento
      • San Francisco, California, Forente stater, 94109
        • Rekruttering
        • Bay Area Structural Heart at Sutter Health
      • San Francisco, California, Forente stater, 94115
        • Aktiv, ikke rekrutterende
        • Kaiser San Francisco Medical Center
      • Stanford, California, Forente stater, 94305
        • Rekruttering
        • Stanford University
    • Colorado
      • Loveland, Colorado, Forente stater, 80538
        • Aktiv, ikke rekrutterende
        • UC Health Northern Colorado (Medical Center of the Rockies)
    • Connecticut
      • Hartford, Connecticut, Forente stater, 06102
        • Rekruttering
        • Hartford Hospital
    • Florida
      • North Naples, Florida, Forente stater, 34102
        • Aktiv, ikke rekrutterende
        • Naples Community Hospital Healthcare System
    • Georgia
      • Atlanta, Georgia, Forente stater, 30309
        • Aktiv, ikke rekrutterende
        • Piedmont Heart Institute
      • Atlanta, Georgia, Forente stater, 30322
        • Aktiv, ikke rekrutterende
        • Emory University Atlanta
    • Illinois
      • Chicago, Illinois, Forente stater, 60612
        • Aktiv, ikke rekrutterende
        • Rush University Medical Center Chicago
      • Elk Grove Village, Illinois, Forente stater, 60007
        • Rekruttering
        • Alexian Brothers Hospital Network
      • Evanston, Illinois, Forente stater, 60201
        • Rekruttering
        • NorthShore University HealthSystem Research Institute Evanston
      • Evanston, Illinois, Forente stater, 60611
        • Rekruttering
        • Northwestern University Chicago
      • New Lenox, Illinois, Forente stater, 60541
        • Rekruttering
        • Silver Cross Hospital
    • Indiana
      • Carmel, Indiana, Forente stater, 46290
        • Aktiv, ikke rekrutterende
        • St. Vincent Medical Group, Inc./ St. Vincent Heart Center of Indiana, LLC
    • Kansas
      • Kansas City, Kansas, Forente stater, 66160
        • Aktiv, ikke rekrutterende
        • University of Kansas Medical Center
      • Wichita, Kansas, Forente stater, 67226
        • Rekruttering
        • Ascension Via Christi St. Francis (Cardiovascular Research Institute of Kansas)
    • Maryland
      • Baltimore, Maryland, Forente stater, 21218
        • Rekruttering
        • Medstar Union Memorial Hospital
    • Massachusetts
      • Boston, Massachusetts, Forente stater, 02115
        • Rekruttering
        • Brigham and Women's Hospital
    • Michigan
      • Detroit, Michigan, Forente stater, 48202
        • Aktiv, ikke rekrutterende
        • Henry Ford Hospital
    • Minnesota
      • Rochester, Minnesota, Forente stater, 55905
        • Aktiv, ikke rekrutterende
        • Mayo Clinic Rochester
      • Saint Cloud, Minnesota, Forente stater, 56303
        • Aktiv, ikke rekrutterende
        • CentraCare Heart and Vascular Center
    • Missouri
      • Kansas City, Missouri, Forente stater, 64111
        • Aktiv, ikke rekrutterende
        • Saint Luke's Hospital
      • St Louis, Missouri, Forente stater, 63110
        • Rekruttering
        • Washington University - Barnes-Jewish Hospital Saint Louis
    • Montana
      • Missoula, Montana, Forente stater, 59802
        • Aktiv, ikke rekrutterende
        • St. Patrick Hospital
    • New Hampshire
      • Lebanon, New Hampshire, Forente stater, 03756
        • Rekruttering
        • Dartmouth-Hitchcock Medical Center, Hanover
    • New Jersey
      • Morristown, New Jersey, Forente stater, 07960
        • Rekruttering
        • Atlantic Health System Morristown
      • New Brunswick, New Jersey, Forente stater, 08901
        • Rekruttering
        • Rutgers Robert Wood Johnson Medical School
      • Ridgewood, New Jersey, Forente stater, 07450
        • Aktiv, ikke rekrutterende
        • The Valley Hospital
    • New York
      • Buffalo, New York, Forente stater, 14203
        • Rekruttering
        • University at Buffalo - Kaleida Health
      • New York, New York, Forente stater, 10032
        • Rekruttering
        • Columbia University Medical Center/NYPH
      • New York, New York, Forente stater, 10021
        • Rekruttering
        • Cornell Medical Center
      • New York, New York, Forente stater, 10458
        • Aktiv, ikke rekrutterende
        • Montefiore Medical Center
    • North Carolina
      • Charlotte, North Carolina, Forente stater, 28204
        • Rekruttering
        • Novant Health and Heart Vascular Institute
      • Charlotte, North Carolina, Forente stater, 28203
        • Aktiv, ikke rekrutterende
        • Carolinas Health System
    • Ohio
      • Cincinnati, Ohio, Forente stater, 45219
        • Rekruttering
        • The Christ Hospital
      • Cleveland, Ohio, Forente stater, 44195
        • Aktiv, ikke rekrutterende
        • The Cleveland Clinic Foundation
    • Oklahoma
      • Oklahoma City, Oklahoma, Forente stater, 73120
        • Rekruttering
        • Oklahoma Cardiovascular Research Group Oklahoma City
      • Tulsa, Oklahoma, Forente stater, 74104
        • Rekruttering
        • Oklahoma Heart Institute
    • Oregon
      • Clackamas, Oregon, Forente stater, 97015
        • Rekruttering
        • Kaiser Portland
      • Portland, Oregon, Forente stater, 97225
        • Aktiv, ikke rekrutterende
        • Providence Heart & Vascular Institute Portland
    • Pennsylvania
      • Harrisburg, Pennsylvania, Forente stater, 17101
        • Fullført
        • Pinnacle Health Harrisburg
      • Pittsburgh, Pennsylvania, Forente stater, 15212
        • Rekruttering
        • Allegheny General Hospital
    • Tennessee
      • Germantown, Tennessee, Forente stater, 38138
        • Aktiv, ikke rekrutterende
        • Methodist Le Bonheur Healthcare
      • Nashville, Tennessee, Forente stater, 37232
        • Rekruttering
        • Vanderbilt University Medical Center
      • Nashville, Tennessee, Forente stater, 37203
        • Rekruttering
        • Centennial Medical Center
      • Nashville, Tennessee, Forente stater, 37205
        • Rekruttering
        • Saint Thomas Health
    • Texas
      • Dallas, Texas, Forente stater, 75230
        • Aktiv, ikke rekrutterende
        • Medical City Dallas Hospital
      • Dallas, Texas, Forente stater, 75226
        • Rekruttering
        • Baylor Heart and Vascular Hospital
      • Houston, Texas, Forente stater, 77004
        • Aktiv, ikke rekrutterende
        • HCA Houston Healthcare Medical Center
      • Houston, Texas, Forente stater, 77030
        • Aktiv, ikke rekrutterende
        • University of Texas Memorial Hermann
      • Plano, Texas, Forente stater, 75093
        • Rekruttering
        • The Heart Hospital Baylor Plano
    • Virginia
      • Norfolk, Virginia, Forente stater, 23507
        • Rekruttering
        • Sentara Norfolk General Hospital
    • Washington
      • Seattle, Washington, Forente stater, 98195
        • Aktiv, ikke rekrutterende
        • University of Washington Seattle
      • Christchurch, New Zealand, 8011
        • Aktiv, ikke rekrutterende
        • Christchurch Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Severe, calcific AS
  2. Native aortic annulus size suitable for SAPIEN X4 THV
  3. NYHA functional class ≥ II
  4. The subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.

Exclusion Criteria:

  1. Anatomical characteristics that would preclude safe femoral placement of the introducer sheath or safe passage of the delivery system
  2. Aortic valve is unicuspid, bicuspid or non-calcified
  3. Pre-existing mechanical or bioprosthetic valve in any position
  4. Severe aortic regurgitation (> 3+)
  5. Severe mitral regurgitation (> 3+) or ≥ moderate mitral stenosis
  6. Need for mitral, tricuspid or pulmonic valve intervention within the next 12 months
  7. Left ventricular ejection fraction < 20%
  8. Cardiac imaging evidence of intracardiac mass, thrombus or vegetation
  9. Left ventricular outflow tract calcification that would increase the risk of annular rupture or significant PVL after THV implantation
  10. Increased risk of coronary artery obstruction after THV implantation
  11. Myocardial infarction within 30 days prior to the study procedure
  12. Hypertrophic cardiomyopathy with subvalvular obstruction
  13. Subjects with planned concomitant ablation for atrial fibrillation
  14. Complex coronary artery disease (CAD) that cannot be optimally treated by percutaneous coronary intervention (PCI)
  15. Any surgical or transcatheter procedure within 30 days prior to the study procedure (unless part of planned strategy for treatment of CAD). Implantation of a permanent pacemaker or implantable cardioverter defibrillator (ICD) is not considered an exclusion.
  16. Any planned surgical or transcatheter intervention to be performed within 30 days following the study procedure (unless part of planned strategy for treatment of CAD)
  17. Endocarditis within 180 days prior to the study procedure
  18. Stroke, transient ischemic attack or neurological signs and symptoms attributed to carotid or vertebrobasilar disease within 90 days prior to the study procedure
  19. Hemodynamic or respiratory instability requiring inotropic or mechanical support within 30 days prior to the study procedure
  20. Renal insufficiency and/or renal replacement therapy
  21. Leukopenia, anemia, thrombocytopenia
  22. Inability to tolerate or condition precluding treatment with antithrombotic therapy
  23. Hypercoagulable state or other condition that increases risk of thrombosis
  24. Absolute contraindications or allergy to iodinated contrast that cannot be adequately treated with premedication
  25. Subject refuses blood products
  26. BMI > 50 kg/m2
  27. Estimated life expectancy < 24 months
  28. Female who is pregnant or lactating
  29. Active SARS-CoV-2 infection or previously diagnosed with COVID-19 with sequelae that could confound endpoint assessments
  30. Participating in another investigational drug or device study that has not reached its primary endpoint
  31. Subject considered to be part of a vulnerable population

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Ikke-randomisert
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: TAVR - Main Cohort

Subjects will undergo transcatheter aortic valve replacement (TAVR)

Implantation of the SAPIEN X4 valve

Eksperimentell: TAVR - Bicuspid Registry

Subjects with bicuspid aortic valve morphology will undergo TAVR

Implantation of the SAPIEN X4 valve

Eksperimentell: TAVR - X4S Registry

Subjects will undergo transcatheter aortic valve replacement (TAVR)

Implantation of the SAPIEN X4S valve

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Non-hierarchical composite of death and stroke
Tidsramme: 1 year

The number of patients that died or had a stroke

1 year

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Favorable outcome per VARC-3: Composite of 1) alive, 2) Kansas City Cardiomyopathy Questionnaire (KCCQ) score ≥ 60, and 3) KCCQ score decrease ≤10 points from baseline
Tidsramme: 1 year

The number of patients that met all of these criteria. The KCCQ is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. An overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.

1 year
Paravalvular leak
Tidsramme: 30 days

Paravalvular leak will be categorized as None, Trace, Mild, Mild-Moderate, Moderate, Moderate-Severe, or Severe

30 days
New permanent pacemaker implantation
Tidsramme: 30 days

The number of patients with this event

30 days

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Tamim M. Nazif, MD, Columbia University
  • Hovedetterforsker: Rahul P. Sharma, MBBS, Stanford University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

20. juni 2022

Primær fullføring (Antatt)

1. juli 2027

Studiet fullført (Antatt)

1. januar 2037

Datoer for studieregistrering

Først innsendt

14. desember 2021

Først innsendt som oppfylte QC-kriteriene

14. desember 2021

Først lagt ut (Faktiske)

29. desember 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

24. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

22. september 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Ja

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere